In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.
about
Pharmacodynamic profile of ertapenem against Klebsiella pneumoniae and Escherichia coli in a murine thigh modelComparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections.In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strainsActivity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh modelSuccessful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.β-Lactams and β-Lactamase Inhibitors: An Overview.In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria.In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers.Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.
P2860
Q33555094-E5DF6554-3CE8-4735-86D3-031C3DBCC447Q33980464-5092DAED-9701-4402-8486-62D811D9BB79Q33982797-F76D17D5-A970-4672-875B-8D160B52DD72Q33983150-71FE8881-2113-48FA-9E80-49FDB77443BAQ35758849-3D12F418-610C-443B-955C-79F813F9A7BDQ36075788-A3562A1D-63B2-4D25-8E3E-5A2525BA42EFQ37120635-CD35975E-43F5-4F6E-B410-4C9185958968Q38872374-6704EC24-80E8-49E3-8C04-1DC8917E9432Q39474748-5F59E881-D0AD-4E8A-917F-4E1C64077EC1Q39477537-62904B8B-8C6A-48A5-8CA4-773C4E75A32BQ39477617-3CD02508-AD80-45AB-A841-BD548BA567B5Q39651410-4C426216-A4B5-488B-90B0-88B372A109C3
P2860
In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
In vitro activities of the pot ...... richia coli clinical isolates.
@ast
In vitro activities of the pot ...... richia coli clinical isolates.
@en
type
label
In vitro activities of the pot ...... richia coli clinical isolates.
@ast
In vitro activities of the pot ...... richia coli clinical isolates.
@en
prefLabel
In vitro activities of the pot ...... richia coli clinical isolates.
@ast
In vitro activities of the pot ...... richia coli clinical isolates.
@en
P2093
P2860
P1476
In vitro activities of the pot ...... richia coli clinical isolates.
@en
P2093
Hammond GG
P2860
P304
P407
P577
1999-05-01T00:00:00Z